Paul Kidwell

Biotech/Pharma PR Professional. Media Relations & Patient Engagement

[Paul Kidwell @paulkidwell]

@h3biomedic@H3Biomedicine pre-clinical, proof-of-concept data published in #NatureMedicine on H3B-8800, first-in-class spliceosome-modulator therapy for genomically identified patients with hematological cancers. https://t.co/pQD9cZQ9B0

[Paul Kidwell @paulkidwell]

Join H3 executives at next week's BIO CEO investor conference. https://t.co/5kvXoT4H43

[Paul Kidwell @paulkidwell]

H3 Biomedicine to Present at 2018 JP Morgan Healthcare Conference. https://t.co/WIaODyRIea

[Paul Kidwell @paulkidwell]

H3 Biomedicine scheduled to present at 2018 JP Morgan Healthcare Conference

[Paul Kidwell @paulkidwell]

Paper in #Cancer Research Underscores #H3 scientists’ commitment to #FGFR4 inhibition for #hepatocellularcarcinoma . https://t.co/3DXLQuIafc

[Paul Kidwell @paulkidwell]

Paper in #Cancer Research Underscores #H3 scientists’ commitment to #FGFR4 inhibition for #hepatocellularcarcinoma . https://t.co/3DXLQuIafc

[Paul Kidwell @paulkidwell]

@h3biomedicine Three academic collaborations in #RNAsplicingbiology presented at #ASH17 that explore the potential of targeting the #spliceosome. Stop by Booth 2107 at #ASH17 to learn more. https://t.co/Pc1Fn8HsZH

[Paul Kidwell @paulkidwell]

H3Biomedicine Three academic collaborations in #RNAsplicingbiology presented at #ASH17 that explore the potential of targeting the #spliceosome. Stop by Booth 2107 at #ASH17 to learn more. https://t.co/Pc1Fn8HsZH

[Paul Kidwell @paulkidwell]

We debut our #ASH17 booth - 2107. Committed to developing novel #bloodcancer medicines for unmet needs in #hematology. Stop by H3Biomedicine Booth 2107 to learn more.

[Paul Kidwell @paulkidwell]

We debut our #ASH17 booth - 2107. Committed to developing novel #bloodcancer medicines for unmet needs in #hematology. Stop by H3Biomedicine Booth 2107 to learn more.

[Paul Kidwell @paulkidwell]

Is a Cure for HIV on the Horizon with #Koronis' Drug Candidate? Forbes - http://t.co/PIsj8LP #hiv [by @KerryDolan]

[Paul Kidwell @paulkidwell]

Last Saturday for Met Opera radio broadcast. Dealing with Puccini-withdrawal. Bring on Dwight, Emmy Lou, and anything with a steel guitar.

[Paul Kidwell @paulkidwell]

Think Larry Summers would take a stay-awake drug if developed by a woman scientist? Sweet dreams, Larry.

[Paul Kidwell @paulkidwell]

Twitt-ku: T-ball kids at bat. Shiny helmets, new ballgloves. Hey, kids, let’s play two.

[Paul Kidwell @paulkidwell]

Twitt-Ku: Moist earth, weeded lawn.
Today I will dig the dirt.
Garden hangover.

[Paul Kidwell @paulkidwell]

Twitt-Ku: Yanks and Sox Play One.
Dance the Late-night Monster Ball.
More tear-stained pinstripes.

[Paul Kidwell @paulkidwell]

ASCO unveils data on 5.14. Envelope please. Any rumblings of new cos. making noise at the meeting or just the usual suspects?

[Paul Kidwell @paulkidwell]

See BizWeek piece on PR by Steve McKee. I might be a bit biased, but agree with his take. http:businessweek.com/smallbiz

[Paul Kidwell @paulkidwell]

@mhuckman Seems like a million years ago since I worked on the Advisory Panel news.Hope the news on IMPACT is good.

[Paul Kidwell @paulkidwell]

@MaverickNY We should talk at some point. Work with handful of cancer biotechs. Happy to speak to you and be a resource.